F537-0225 Screening compound: 6-{[4-(4-chlorobenzoyl)piperazin-1-yl]sulfonyl}-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one

F537-0225 Screening compound: 6-{[4-(4-chlorobenzoyl)piperazin-1-yl]sulfonyl}-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one
F537-0225 Screening compound: 6-{[4-(4-chlorobenzoyl)piperazin-1-yl]sulfonyl}-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F537-0225
6-{[4-(4-chlorobenzoyl)piperazin-1-yl]sulfonyl}-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F537-0225

Molecular Formula

C20H20ClN3O5S (C20 H20 ClN3 O5 S)

Compound Name

6-{[4-(4-chlorobenzoyl)piperazin-1-yl]sulfonyl}-2-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one

IUPAC name

6-{[4-(4-chlorobenzoyl)piperazin-1-yl]sulfonyl}-2-methyl-34-dihydro-2H-14-benzoxazin-3-one

SMILES

CC1Oc(ccc(S(N(CC2)CCN2C(c(cc2)ccc2Cl)=O)(=O)=O)c2)c2NC1=O

InChI

InChI=1S/C20H20ClN3O5S/c1-13-19(25)22-17-12-16(6-7-18(17)29-13)30(27,28)24-10-8-23(9-11-24)20(26)14-2-4-15(21)5-3-14/h2-7,12-13H,8-11H2,1H3,(H,22,25)/t13-/m1/s1

InChI Key

MREWLFXKWSBXPT-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD27173688

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

449.91

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.162

Distribution Coefficient, logD

2.162

Water Solubility, LogSw

-3.29

Polar Surface Area

81.014

Acid Dissociation Constant (pKa)

10.63

Base Dissociation Constant (pKb)

-2.98

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.00

F537-0225 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with F537-0225 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F537-0225?
Check Price and Availability of F537-0225, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F537-0225 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F537-0225
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F537-0225
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F537-0225 available by request